給藥（藥劑送達）部門的奈米科技的使用：2011-2021年 是由出版商Cientifica Ltd在2011年10月所出版的。
這份英文市場調查報告書包含212 Pages 價格從美金4000起跳。
醫療部門是最早接受奈米科技的市場定位、今後10年中是紀錄成為最高成長率的使用者部門展望。奈米科技的應用的優點領域部分、癌症治療的關係為目標的給藥（藥劑送達）被廣泛的認識。奈米科技給藥的有効市場從2010年到2021年為止年平均成長率49.96%、2021年預測達1,361億3,400萬美金的市場規模。
本報告書內容包括:全球的主要地區之奈米科技給藥的發展趨勢之調查分析、奈米科技的概要、醫學・生體醫學部門的奈米科技之應用和其重要性、優點、引進推動因素、給藥部門的應用範例和開發階段、已認定臨床的奈米能力・奈米結晶製劑、技術引進的指南、有效市場的市場規模預測（∼2021年）等彙整、內容綱要摘記如下:
實施摘要
第1章 介紹・調查方法
第2章 介紹：奈米科技和醫療
- 奈米科技：概要
- 醫學・生體醫學部門的重要性
- 醫學・生體醫學部門的需求
- 奈米科技的醫學・生體醫學部門的引進推動因素
- 奈米粒子給藥的引進推動因素
- 高齡者人口的增大
- 更低價格的醫療需求
- 公共醫療
- 創新的需求
- 社會的責任
- 醫學・生體醫學部門中最重要的奈米科技引進領域
- 給藥
- 醫學・生物醫學的診断
- 再生醫療・再生醫學
- 醫療・醫藥品部門的其他適用領域
- 奈米科技的給藥部門之影響
第3章 醫學・生體醫學部門的奈米科技的引進：主要阻礙因素
- 醫學・生體醫學部門的奈米科技的引進：主要阻礙因素
- 奈米毒性・奈米汚染・奈米安全
- 奈米治療的倫理考察
- 奈米相關規範的整備遲緩
- 醫學・生體醫學部門的奈米科技引進：現在及未來的課題
- 奈米安全和風險管理
- 奈米相關規範
- 奈米醫療產業
- 創新的持續
- 合作・協力
- 市場分析（2000-2010年）
- 市場預測（∼2021年）
第4章 給藥部門的奈米科技
- 給藥部門所使用的主要奈米科技
- 奈米醫藥品
- 給藥的奈米科技
- 給藥的奈米生物科技
- 奈米粒子給藥的解析技術
- 奈米能力
- 奈米科技基礎的奈米能力替代品
- 最重要技術
- 給藥部門所使用的主要奈米科技的開發階段
- 所上市的臨床已認定奈米能力製劑
- 所上市的臨床已認定奈米結晶製劑
- 現在及未來的應用
- 市場分析：各種市場區分
- 技術引進指南
- 產品開發預測：奈米能力基礎的製劑
- 產品開發預測：奈米結晶基礎的製劑
- 市場預測：市場區分分類（∼2021年）
- SWOT分析（2011-2021年）
圖表
Abstract
The healthcare market is poised to see some of the earliest benefits of
nanotechnology. Over the next decade, it will be one of nanotech's highest
growth sectors. Targeted drug delivery therapies for the treatment of cancer
is one of the most commonly cited nano-healthcare benefits. Cientifica's
report, Nanotechnology in Drug Delivery 2011, gives a comprehensive analysis
and geographic breakdown of the current nanotechnology drug delivery market
and its most relevant technologies. It also provides a forecast for the size
of total addressable markets and percent share of those key technologies to
2021.
Some forecasts have predicted the nanotechnology market to reach close to a
trillion dollars by 2015, presenting investors with unique opportunities.
However, the market for applications of nanotechnology is complex,
multidisciplinary and highly segmented. It is therefore essential to gain an
understanding of which market sectors nanotechnology is likely to impact most
profoundly in the near term.
Since we now know most (if not all) biological processes occur at the
nanoscale, the application of life science principles - studying the causes of
biological phenomena at the molecular level - means medical and biomedical
research is increasingly using a bottom-up (rather than the top-down)
approach. The low bioavailability resulting from traditional oral and
intravenous drug delivery methods and the market forces at work in the
pharmaceutical industry, where patents expire after a relatively short period
of time unless a novel form of drug delivery is developed that will extend the
patent, are two major forces that will fuel the growth of the nanotech drug
delivery market. The third factor at play is a combination of improved global
health and a correspondingly dramatic increase in the size of the global aging
population.
This report provides insight into the possibilities of targeted nanotech drug
delivery and its market potential over the next decade.
Market Scope
This report provides an in-depth presentation of recent developments in
nanotech drug delivery (NDD) and provides market opportunities to 2021, for
the largest economies in the Americas, Asia, Europe and the rest of the world.
Two market analyses are presented;
- The historical market growth for NDD between 2000-2010
- Market forecast for NDD from 2011 to 2021
Both sets of data are segmented into market by geographical region (US$
millions, % share, and compound annual growth rates by country) for America;
Asia, Europe, and Rest of the World (key economies only) and by technology
type (US$ millions, percent share and compound annual growth rate). Technology
types examined include:
- Solubility & Bioavailability
- Targeted Delivery
- Drug Nanocrystals
- Total Nanocarriers
- Liposomes
- Carbon nanotubes
- Gold Nanocarriers
- Dendrimers
- Micelles
- Polymer-based Nanocarriers
- Nanoshells
- Ceramic Nanocarriers
- Calcium phosphate Nanocarriers
Summary of findings (current and future)
The market growth for NDD in the period 2000-2010 shows it reached US$1,030
million by 2010.
The forecast for nanotech drug delivery to 2021 shows that the total
addressable market will reach US$ 136,134 million by 2021 and the compound
annual growth rate (CAGR) is estimated to be 49.96% over the period 2010-20121.
Also included in the report is:
- An overview of nanotechnology;
- Identification of several key drivers for nanotechnology adoption in
medicine and biomedicine;
- The most important fields for the adoption of nanotechnology in medicine;
and
- An explanation of how nanotechnology is already having an impact on the
drugs delivery sector through several relevant case studies.
In addition to an examination of general trends, Nanotechnology in Drug
Delivery 2011 identifies five current & future challenges to as well as the
major barriers to adoption of nanotechnology in medicine and biomedicine and
provides a Technology Adoption Roadmap.
The report examines the stage of development of key nanotechnologies used in
drug delivery, sorted by applications, including
- Nanopharmaceuticals
- Nanobiotechnology in drug delivery
- Analytical techniques for nanoparticle drug delivery
- Clinically approved nanocarrier-based formulations present on the market
and in the pipeline
- Clinically approved nanocrystals-based formulations present on the market
and in development
- Nanotechnology-based alternatives to nanocarriers in drug delivery
- Present and future applications
Methodology
Information contained within this report is procured from several sources.
These include proprietary research carried out by Cientifica, primary sources
including interviews with industry and academics, and secondary sources
including online publications and datasets to determine:
- current size of pharma, drug delivery and nanotech drug delivery markets
including compound annual growth rates (CAGR)
- population sizes/growth to 2021
- global and regional health statistics
- patent data including expiration dates
- pharma company mergers and acquisitions
- company and university R&D expenditure
- trends in governments' healthcare spending figures including CAGR
- current drug delivery market as percent of whole pharma market including
CAGR
- highest grossing drug delivery products currently on the market
- drug delivery research and publication statistics.
This data is analysed to provide the current nanotech drug delivery market
(2010) and global total addressable market for products for the next decade.
Table of Contents
Table of Exhibits
Executive Summary
Chapter 1
- Introduction and Methodology
- Report Scope
- Thematic Scope
- Scope of Data Analysis
- Temporal Scope of Analysis
- Geographical Scope
- Report objective
- Methodology
- Cientifica, Ltd Nanotechnology Model
- Major Assumptions
- Market Values And Publishing Activity
- Publishing Activity And TAM (2000-2010 period)
- Calculation of CAGR
- The Nanoscale
Chapter 2
- Introduction to Nanotechnology & Medicine
- Overview of nanotechnology
- Why is Nanotechnology A Critical Application for Medicine and
Biomedicine?
- Why Nanotechnology Is Needed for Medicine and Biomedicine?
- What are the Key Drivers for Adoption of Nanotechnology in Medicine and
- Biomedicine?
- Drivers For Nanoparticle Drug Delivery
- THE AIM OF DRUG TARGETING
- REASONS WHY THE DRUG DELIVERY MARKET IS RAPIDLY EXPANDING
- MARKET DRIVERS FOR ENHANCED DRUG DELIVERY
- Increasing Proportion of The Aging Population
- Demand More Affordable Health Care
- Public Health - Ending disease
- Demand for More Innovation
- Social responsibility
- The Most Important Fields in The Adoption of Nanotechnology in Medicine
and Biomedicine
- Nanotechnology in Drug Delivery
- Nanotechnology in Medical and Biomedical Diagnostics
- Nanotechnology in Regenerative Medicine and Tissue Engineering
- Other Applications For Nanomaterials In The Medical And Pharmaceutical
Sector
- How Nanotechnology is Already Having an Impact on The Drug Delivery Sector
- Case Study 1 - Magnetic Field Acts as "Remote Control" to
Deliver Nanomedicine
- Case Study 2 - Adaptive Micro and Nanoparticles: Temporal
Control Over Carrier
- Properties to Facilitate Drug Delivery
- Case Study 3 - Fabrication of a Nanocarrier System Through
Self-Assembly of
- Plasma Protein And Its Tumour Targeting
- Case Study 4 - IBM And The Institute of Bioengineering and
Nanotechnology
- Find Breakthrough For MRSA Treatment - New Molecular Structures Could
Fight
- Infectious Diseases Better Than Conventional Antibiotics
- References
Chapter 3
- Key Barriers to The Adoption of Nanotechnology in Medicine and Biomedicine
- Nanotoxicity Nanopollution and Nanosafety
- Ethical considerations of nanotherapies
- Delayed Nanoregulation
- Current & Future Challenges of The Adoption of Nanotechnology in Medicine
and Biomedicine
- Current & Future Challenges of Nanosafety And Risk Management
- Current & Future Challenges of Nanoregulation
- Current & Future Challenges of Nanomedicine Industry
- Current & Future Challenges of Sustained Innovation
- Current & Future Challenges of Cooperation
- Market Analysis (2000-2010) Without Segmentation
- Market Forecast to 2021 Without Segmentation
- References
Chapter 4
- Nanotechnology in Drug Delivery
- Overview of The Key Nanotechnologies Used in Drug Delivery Sorted by
- Applications
- Nanopharmaceuticals
- Nanotechnology In Drug Delivery
- Nanobiotechnology In Drug Delivery
- Analytical Techniques For Nanoparticle Drug Delivery
- PROPERTIES
- PRODUCTION OF NANOPARTICLES
- MEASURING DISPERSION OF NANOPARTICLES
- ANALYSIS OF CARRIER SYSTEMS
- Nanocarriers
- CLASSIFICATION OF NANOCARRIERS
- MULTIFUNCTIONAL NANOCARRIERS - DRUG DELIVERY AND
- MEDICAL/BIOMEDICAL DIAGNOSTICS
- NANOCARRIERS AS DRUG CARRIERS
- WHAT CAN NANOPARTICLES DO IN DRUG DELIVERY?
- POLYMER-BASED NANOCARRIERS (POLYMERIC NANOPARTICLES)
- LIPID-BASED NANOCARRIERS
- ORGANIC NANOCARRIERS
- INORGANIC NANOCARRIERS
- DISADVANTAGES ASSOCIATED WITH NANOCARRIERS
- Nanotechnology-Based Alternatives to Nanocarriers in Drug Delivery
- DRUG NANOCRYSTALS: NANOSIZING THE DRUGS
- The Most Relevant Key Technologies in The Key Area of Nanotechnology in
Drug Delivery
- Stage of Development of Key Nanotechnologies Used in Drug Delivery
- Clinically Approved Nanocarrier-Based Formulations With Presence in The
Market
- THE FIRST NANOPARTICLE DRUG DELIVERY SYSTEM REACHES THE MARKET
- Clinically Approved Nanocrystals-Based Formulations With Presence in the
Market
- Present And Future Applications
- Market Analysis With Segmentation
- MARKET BY COUNTRY (2000-2010)
- MARKET BY KEY TECHNOLOGY (2000-2010)
- Technology Adoption Roadmap
- Projected Product Pipeline For Nanocarrier-Based Drug Formulations In
Drug Delivery Market
- OVERVIEW OF NANOPARTICLE DRUG DELIVERY SYSTEM (DDS) IN VARIOUS
APPLICATIONS
- AVAILABLE APPLICATIONS OF NANOPARTCILE IN DRUG DELIVERY
- Projected Product Pipeline For Nanocrystals-Based Drug Formulations In
Drug Delivery Market;
- SEMAPIMODR (CYTOKINE, PHARMASCIENCES)
- PAXCEED"!
- THERALUX"!
- NUCRYSTR
- Market Forecast to 2021, With Segmentation
- MARKET FORECAST BY COUNTRY BY 2021
- MARKET FORECAST BY KEY TECHNOLOGY BY 2021
- SWOT Analysis (2011-2021 period)
- References
Table of Exhibits
Chapter One. Introduction and Methodology
- Exhibit 1.1
- Formula for the calculation of the Compound Annual Growth Rate (CAGR),
(top).
- Formula for the calculation of the Compound Annual Growth Rate (CAGR) in
this report, for the 2011-2021 period, (bottom) [2].
- Exhibit 1.2
- Formula for the verification of the calculated values of the Compound
Annual Growth Rate (CAGR), (top).
- Formula for the verification of the calculated values of the Compound
Annual Growth Rate (CAGR) in this report, for the 2011-2021 period, (bottom)
[2].
- Exhibit 1.3
- The equivalence between 1 nm in meter (top). The equivalence between 1
meter in nanometre (bottom).
Chapter Two: Introduction to Nanotechnology & Medicine
- Exhibit 2.1
- Illustration of the fact that the periodic table of elements, as we know
it (at meter scale) governed by classic Newtonian laws of physics. However,
when perceived at nanoscale, those elements are governed by the laws of
quantum physics.
- Exhibit 2.2
- Proportion of the population aged over 65 and over 80 [7].
- Exhibit 2.3
- Illustration of a diagram of each property of nanocarriers (size, shape,
surface chemistry and mechanical properties) and their parameters subjected
to optimization in order to improve their efficiency [10].
Chapter Three: Technology Adoption Roadmap
- Exhibit 3.1
- Specified expected barriers in the development of particular types of
nanoparticles (Courtesy of CienNanoroadmap Synthesis Report), [6].
- Exhibit 3.2
- Illustration of the measures adoption roadmap to combat/attenuate the
key barriers to the adoption of nanotechnology in medicine and biomedicine
(Source: Cientifica, Ltd.).
- Exhibit 3.3
- Table representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in drug delivery, without segmentation, source: Cientifica
(all figures US$ Million Dollars).
- Exhibit 3.4
- Line chart representing Total Addressable Market, TAM (2000-2010), for
nanotechnology in drug delivery, without segmentation, source: Cientifica
(all figures US$ Million Dollars).
- Exhibit 3.5
- Bar chart representing Total Addressable Market, TAM (2000-2010), for
nanotechnology in drug delivery, without segmentation, source: Cientifica
(all figures US$ Million Dollars).
- Exhibit 3.6
- Table representing the Total Addressable Market, TAM forecast by 2021
(for the 2011- 2021 period), for nanotechnology in drug delivery, without
segmentation, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 3.7
- Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery,
without segmentation, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 3.8
- Bar chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011- 2021 period), for nanotechnology in drug delivery,
without segmentation, source: Cientifica (all figures US$ Million Dollars).
Chapter Four: Nanotechnology in Drug Delivery
- Exhibit 4.1
- Typical Image of Colloidal Gold Nanoparticles [1].
- Exhibit 4.2
- Examples of nanocarriers used for targeting cancer. (A) A whole range of
delivery agents are possible but the main components typically include a
nanocarrier, a targeting moiety conjugated to the nanocarrier and a cargo
(such as the desired chemotherapeutic drugs); (B) Schematic diagram of the
drug conjugation and entrapment processes. The chemotherapeutics could be
bound to the nanocarrier, as in the use of polymer - drug conjugates,
dendrimers and some particulate carriers or they could be entrapped inside
the nanocarrier [3].
- Exhibit 4.3
- Schematic representation of different mechanisms of drug delivery to
tumours using nanocarriers. Polymeric nanoparticles are shown as
representative nanocarriers (circles).
- Passive tissue targeting is achieved by extravasation of nanoparticles
through increased permeability of the tumour vasculature and ineffective
lymphatic drainage (EPR effect).
- Active cellular targeting (inset) can be achieved by functionalizing the
surface of nanocarriers with ligands that induce cell-specific recognition
and binding. The
- nanocarriers can (a) release their contents in close proximity to the
target tumour cells; (b) attach to the membrane of the tumour cell and play
the role of an extracellular sustainedrelease drug depot; or (c) internalize
into the tumour cell [3].
- Exhibit 4.4
- Advantages and disadvantages of different methods for the production of
drug nanocrystals [6].
- Exhibit 4.5
- Representative examples of clinically approved nanocarrier-based drug
formulations with presence on the market [4].
- Exhibit 4.6
- Some examples of nano-based platforms and their current stage of
development for use in cancer therapy [3].
- Exhibit 4.7
- Representative examples of clinically approved nanocrystals-based drug
formulations with presence on the market [6]
- Exhibit 4.8
- Table representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in drug delivery, all countries studied, source: Cientifica
(all figures US$ Million Dollars).
- Exhibit 4.9
- 3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, by world regions and countries, source:
Cientifica (all figures in percentage).
- Exhibit 4.10
- Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in drug delivery, by world regions and countries,
source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.11
- Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in drug delivery, by world regions and countries, source:
Cientifica (all figures US$ Million Dollars).
- Exhibit 4.12
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010), for nanotechnology in drug delivery, by world
regions and countries, source:
- Cientifica (all figures US$ Million Dollars).
- Exhibit 4.13
- 3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010), for nanotechnology in drug delivery, by world regions and
countries, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.14
- 3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, all world regions and countries
studied, source: Cientifica (all figures in percentage).
- Exhibit 4.15
- Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in drug delivery, all world regions and countries
studied, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.16
- 3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, European Union countries studied,
source: Cientifica (all figures in percentage).
- Exhibit 4.17
- Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in drug delivery, European Union countries studied,
source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.18
- Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in drug delivery, European Union countries studied,
source: Cientifica (all
- figures US$ Million Dollars).
- Exhibit 4.19
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010), for nanotechnology in drug delivery, European
Union countries studied, source: Cientifica (all figures US$ Million
Dollars).
- Exhibit 4.20
- 3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010), for nanotechnology in drug delivery, European Union countries
studied, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.21
- 3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, Asian countries studied, source:
Cientifica (all figures in
- percentage).
- Exhibit 4.22
- Horizontal bar graph representing the Total Addressable Market, TAM In
2010, for nanotechnology in drug delivery, Asian countries studied, source:
Cientifica (all figures US$ Million Dollars).
- Exhibit 4.23
- Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in drug delivery, Asian countries studied, source:
Cientifica (all figures US$ Million Dollars).
- Exhibit 4.24
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010), for nanotechnology in drug delivery, Asian
countries studied, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.25
- 3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010), for nanotechnology in drug delivery, Asian countries studied,
source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.26
- Table representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in drug delivery, all most relevant key technologies, source:
Cientifica (all figures US$ Million Dollars).
- Exhibit 4.27
- 3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, all key technologies studied, source:
Cientifica (all figures in percentage).
- Exhibit 4.28
- Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in drug delivery, all key technologies studied,
source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.29
- Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in drug delivery, all key technologies studied, source:
Cientifica (all figures
- US$ Million Dollars).
- Exhibit 4.30
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010) , for nanotechnology in drug delivery, all key
technologies studied, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.31
- 3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010) , for nanotechnology in drug delivery, all key technologies
studied, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.32
- 3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, nanocarriers as a whole, source:
Cientifica (all figures in
- percentage).
- Exhibit 4.33
- Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in drug delivery, nanocarriers as a whole, source:
Cientifica (all figures US$ Million Dollars).
- Exhibit 4.34
- Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in drug delivery, nanocarriers as a whole, source:
Cientifica (all figures US$ Million Dollars).
- Exhibit 4.35
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010) , for nanotechnology in drug delivery, nanocarriers
as a whole, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.36
- 3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010) , for nanotechnology in drug delivery, nanocarriers as a whole,
source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.37
- 3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, nanocarriers versus drug nanocrystals,
source: Cientifica (all figures in percentage).
- Exhibit 4.38
- Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in drug delivery, nanocarriers versus drug nanocrystals,
source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.39
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010) , for nanotechnology in drug delivery, nanocarriers
versus drug nanocrystals, source: Cientifica (all figures US$ Million
Dollars).
- Exhibit 4.40
- 3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010) , for nanotechnology in drug delivery, nanocarriers versus drug
nanocrystals, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.41
- 3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, impact of drug solubility and drug
bioavailability, source: Cientifica (all figures in percentage).
- Exhibit 4.42
- Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in drug delivery, impact of drug solubility and drug
bioavailability, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.43
- 3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in drug delivery, impact of targeted delivery, source:
Cientifica (all figures in percentage).
- Exhibit 4.44
- Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in drug delivery, impact of targeted delivery, source:
Cientifica (all figures US$ Million Dollars).
- Exhibit 4.45
- In vivo effects of nanocrystals-based drug formulations [6].
- Exhibit 4.46
- Table representing the Total Addressable Market, TAM forecast by 2021
(for the 2011- 2021 period), for nanotechnology in drug delivery, by world
regions / countries, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.47
- 3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, by world regions, source:
Cientifica (all figures in percentage).
- Exhibit 4.48
- Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, by world regions,
source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.49
- Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by
world regions, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.50
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in drug delivery, by world regions, source: Cientifica (all figures US$
Million Dollars).
- Exhibit 4.51
- 3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug
delivery, by world regions, source: Cientifica (all figures US$ Million
Dollars).
- Exhibit 4.52
- 3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, by all world regions / countries
studied, source: Cientifica (all figures in percentage).
- Exhibit 4.53
- Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, by all world regions
/ countries studied, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.54
- Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all
world regions / countries studied, source: Cientifica (all figures US$
Million Dollars).
- Exhibit 4.55
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in drug delivery, by all world regions / countries studied, source:
Cientifica (all figures US$ Million Dollars).
- Exhibit 4.56
- 3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug
delivery, by all world regions / countries studied, source: Cientifica (all
figures US$ Million Dollars).
- Exhibit 4.57
- 3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, European Union countries studied,
source: Cientifica (all figures in percentage).
- Exhibit 4.58
- Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, European Union
countries studied, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.59
- Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery,
European Union countries studied, source: Cientifica (all figures US$
Million Dollars).
- Exhibit 4.60
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in drug delivery, European Union countries studied, source: Cientifica (all
figures US$ Million Dollars).
- Exhibit 4.61
- 3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug
delivery, European Union
- countries studied, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.62
- 3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, Asian countries studied, source:
Cientifica (all figures in percentage).
- Exhibit 4.63
- Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, Asian countries
studied, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.64
- Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian
countries studied, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.65
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in drug delivery, Asian countries studied, source: Cientifica (all figures
US$ Million Dollars).
- Exhibit 4.66
- 3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug
delivery, Asian countries studied, source: Cientifica (all figures US$
Million Dollars).
- Exhibit 4.67
- Table representing the Total Addressable Market, TAM forecast by 2021
(for the 2011- 2021 period), for nanotechnology in drug delivery, all most
relevant key technologies, source: Cientifica (all figures US$ Million
Dollars).
- Exhibit 4.68
- 3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, all key technologies studied,
source: Cientifica (all figures in percentage).
- Exhibit 4.69
- Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, all key technologies
studied, source: Cientifica (all figures in percentage).
- Exhibit 4.70
- Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery, all
key technologies studied,
- source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.71
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in drug delivery, all key
- technologies studied, source: Cientifica (all figures US$ Million
Dollars).
- Exhibit 4.72
- 3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug
delivery, all key technologies studied, source: Cientifica (all figures US$
Million Dollars).
- Exhibit 4.73
- 3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, nanocarriers as a whole, source:
Cientifica (all figures in percentage).
- Exhibit 4.74
- Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, nanocarriers as a
whole, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.75
- Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery,
nanocarriers as a whole, source: Cientifica (all figures US$ Million
Dollars).
- Exhibit 4.76
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in drug delivery, nanocarriers as a whole, source: Cientifica (all figures
US$ Million Dollars).
- Exhibit 4.77
- 3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug
delivery, nanocarriers as a whole, source: Cientifica (all figures US$
Million Dollars).
- Exhibit 4.78
- 3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, nanocarriers versus drug
nanocrystals, source: Cientifica (all figures in percentage).
- Exhibit 4.79
- Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, nanocarriers versus
drug nanocrystals, source:
- Cientifica (all figures US$ Million Dollars).
- Exhibit 4.80
- Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery,
nanocarriers versus drug
- nanocrystals, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.81
- 3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in drug delivery, nanocarriers versus drug nanocrystals, source: Cientifica
(all figures US$ Million Dollars).
- Exhibit 4.82
- 3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug
delivery, nanocarriers versus drug nanocrystals, source: Cientifica (all
figures US$ Million Dollars).
- Exhibit 4.83
- 3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, impact of drug solubility and
drug bioavailability, source: Cientifica (all figures in percentage).
- Exhibit 4.84
- Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, impact of drug
solubility and drug bioavailability, source: Cientifica (all figures US$
Million Dollars).
- Exhibit 4.85
- Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery, impact
of drug solubility and drug bioavailability, source: Cientifica (all figures
US$ Million Dollars).
- Exhibit 4.86
- 3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in drug delivery, impact of targeted delivery,
source: Cientifica (all figures in percentage).
- Exhibit 4.87
- Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in drug delivery, impact of targeted
delivery, source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.88
- Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in drug delivery, impact
of targeted delivery,
- source: Cientifica (all figures US$ Million Dollars).
- Exhibit 4.89
- SWOT analysis to evaluate the strengths, weaknesses, opportunities and
threats involved in nanotechnology in drug delivery In the scope of the
technology adoption roadmap (during the 2011-2021 period).
Appendix
- Exhibit A.1
- Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: North America; country: USA.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
- Exhibit A.2
- Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: European Union; country:
Germany. Organizations are ordered first by descending order of total
articles published and then ordered alphabetically (increasing order), if
applicable.
- Exhibit A.3
- Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: European Union; country:
France. Organizations are ordered first by descending order of total
articles published and then ordered alphabetically (increasing order), if
applicable.
- Exhibit A.4
- Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: European Union; country: UK.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
- Exhibit A.5
- Table of the organizations with publishing activity in PubMed
periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug
Delivery. Country: Russian Federation. Organizations are ordered
alphabetically (increasing order).
- Exhibit A.6
- Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: India.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
- Exhibit A.7
- Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: India.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
- Exhibit A.8
- Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: Japan.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
- Exhibit A.9
- Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: P R China.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
- Exhibit A.10
- Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: South Korea
(Republic of Korea). Organizations are ordered first by descending order of
total articles published and then ordered alphabetically (increasing order),
if applicable.
- Exhibit A.11
- Table of the organizations with publishing activity in PubMed
periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug
Delivery. Asia; country: Taiwan. Organizations are ordered first by
descending order of total articles published and then ordered alphabetically
(increasing order), if applicable.
利用奈米技術的藥物傳遞，預計2021年時達到1,361億3,400萬美元規模
2011年12月05日
Global Information, Inc.已開始銷售Cientifica Ltd所發行的報告書「Nanotechnology in Drug Delivery 2011 - 2021 (給藥（藥劑送達）部門的奈米科技的使用：2011-2021年)」
利用奈米技術的藥物傳遞系統(DDS)，促使原有的藥劑送達方法發生戲劇性的變化，已確立多樣化製劑的新市場機會。而且，重新登場的DDS企業，在疾病治療方面已開闢全新的時代。
利用奈米技術的藥物傳遞方法，使新的化合物製劑化方法發生變化。另一方面，延長原有藥效成分的生命週期。
利用奈米DDS預計於2012年之前將從現在的4％擴大到15％以上的市占率。
然因尚屬初期階段，2015年以後，利用奈米技術預計將獲得大部分的市場。總之，將獲得幾近藥物傳遞市場的90％。將完全改變DDS製劑的設計。
調查結果的要點
從2000年開始到2010年的奈米技術傳遞(NDD)市場有成長，2010年的市場規模達到11億3,000萬美元。
奈米技術傳遞的有效市場，預測將從2010年到2021年以複合年成長率(CAGR)49.96％擴大，2021年時達到1,361億3,400萬美元。
|
